Our previous findings demonstrated that DAPK1 is aberrantly overexpressed in the hippocampus of individuals with AD and might be a critical regulator of both tau and APP due to its ability to regulate tau function and phosphorylation and control APP processing and Aβ secretion [10,11,14,16]. The gene discussed is MAPT; the disease is Alzheimer disease.